'This cell therapy Parkinson's program is truly innovative and exemplifies the powerful convergence of exciting academic discovery with the uncompromising quality of a global pharmaceutical leader.' ...

May 11 (Reuters) - Meta CEO Mark Zuckerberg backed-Cellular Intelligence has acquired Danish drugmaker Novo Nordisk's cell therapy candidate for Parkinson's disease, the biotech firm said on Monday.

Cellular Intelligence has secured global rights to Novo Nordisk's Parkinson's program, a clinical-stage allogeneic cell therapy for Parkinson's disease with FDA Fast Track Designation. Cellular ...

Seven months after Novo Nordisk abandoned its push into cell therapy, the pharma’s Parkinson’s disease program looks like it’s secured a happy ending via a deal with Cellular Intelligence. The AI ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

PD, an experimental Parkinson’s cell therapy connected to Novo Nordisk. In return, the pharmaceutical giant, according to Drug Discovery Trends, received equity in the startup and retained rights to ...

Ozempic maker Novo Nordisk agreed to sell an experimental cell therapy for Parkinson's disease to Cellular Intelligence and take a stake in the U.S. startup, Cellular Intelligence said Monday. Novo ...

Research shows that consciousness is rooted in living intelligence. The future of our mental health depends on the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...